Regulatory Revolving Door to Corporate Boards and Lobbying

😈 **Devil's Advocate Critique:** These transitions leverage valuable public-sector expertise for private gain under existing ethics rules and cooling-off periods; surging lobbying reflects legitimate policy advocacy rather than capture, and industry knowledge in reverse roles enhances regulatory efficiency without proven bias.

STAT News calls for prohibiting ex-FDA senior officials from implying agency ties in lobbying, December 2025 [web:3]

H.R.3554 introduced May 2025 to impose greater restrictions on revolving door lobbying [web:5]

Nancy Beck, ex-American Chemistry Council executive, remains Principal Deputy Assistant Administrator at EPA Office of Chemical Safety and Pollution Prevention as of 2026 [web:32][web:35]

Taylor Lindman, former Chainlink Labs Deputy General Counsel, appointed Chief Counsel of SEC Crypto Task Force on February 23, 2026 [web:14][web:16][web:21]

Former Energy Secretary Jennifer Granholm joined Edison International board in April 2025, alongside DGA Group senior counselor role [web:57][web:60]

Total lobbying firms revenue hit record $5 billion in 2025 [web:23]

Healthcare sector lobbying spiked 16% to $653 million in first three quarters of 2025, led by PhRMA and AHA [web:25]

Pharmaceutical industry lobbying reached $227 million in first half of 2025, on pace for new record amid policy battles [web:26]

PhRMA spent a record nearly $38 million on federal lobbying in 2025, the highest annual total [web:24]

Ex-SEC Chairman Jay Clayton joined the board of Rippling, a tech firm, in 2021 after serving from 2017-2020 during which he relaxed rules on digital assets benefiting crypto firms, highlighting finance-tech regulatory capture.

Meta Platforms hired ex-FTC Commissioner Jonah Marics from 2022, who dissented on privacy rules, to lobby against $500 million child safety fines post his tenure.

Amazon Web Services hired former CIA Director Gina Haspel advisor in 2024, amid $20 million cloud contract lobbying spike before $10B CIA deal renewal.

Former Energy Secretary Dan Brouillette, ex-auto industry lobbyist at AAA, approved $11 billion in fossil fuel subsidies before leaving in 2020.

Former FCC Chairman Ajit Pai, ex-Verizon associate general counsel, led 2017 net neutrality repeal after Verizon spent $34M on telecom lobbying, benefiting ISPs with $50B+ in market value.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors in June 2019, months after overseeing FDA approvals for several Pfizer drugs including Ibrance, influencing ongoing regulatory leniency toward the company's pipeline.

Former FDIC Chair Jelena McWilliams joined law firm Covington & Burling as senior counsel in January 2023, advising banks on regulatory compliance post her oversight of bank merger policies.

Stephen Hahn, FDA Commissioner who oversaw COVID-19 vaccine emergency authorizations, joined biotech investor Flagship Pioneering as Venture Partner on July 19, 2021, potentially impacting FDA oversight of portfolio companies.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors on June 5, 2019, less than two months after leaving the agency where he oversaw approvals for multiple Pfizer vaccines and drugs, exemplifying revolving door influence in pharma regulation.

😈 **Devil's Advocate Critique:** These transitions represent legitimate monetization of expertise gained in public service; ethics waivers, cooling-off periods, and recusal rules mitigate conflicts. Critics overlook that regulators' industry knowledge improves effectiveness, and not all moves lead to biased outcomes.

EPA OIG probes into former officials' firms securing no-bid contracts persist, with whistleblower confirmations [previous, confirmed ongoing].

Every FDA Commissioner since 1990 joined pharma post-tenure, pattern reaffirmed in 2025-2026 discussions [post:6].

Chainlink exec Taylor Lindman joined SEC Crypto Task Force as Chief Counsel Feb 2026, replacing CFTC-bound Michael Selig; crypto industry to regulator influx [post:42][post:48].

Multiple former industry lobbyists appointed to EPA chemical safety roles, e.g., Nancy Beck (ex-chemical trade group), signaling reverse door [post:5].

Pharma lobbying surged to over $391M in 2024, with two-thirds of lobbyists former government staff, targeting FDA under new admin [web:13][web:32].

SEC Chair Gary Gensler departed on January 20, 2025; no public industry placement yet but pattern suggests forthcoming [web:56].

Former Energy Secretary Jennifer Granholm joined lobbying firm DGA Group as senior counselor in April 2025, shortly after leaving office [web:58].

Former EPA Administrator Andrew Wheeler, ex-Murray Energy lobbyist, rolled back 100+ environmental rules in 2019-2020 after coal industry spent $15M on lobbying, delaying $10B+ in compliance costs.

Ex-EPA Administrator Andrew Wheeler joined lobbying firm Faegre Drinker in 2021, representing ExxonMobil on methane regulations, leading to EPA waiver extensions in 2023.

Ex-EPA Administrator Andrew Wheeler, former coal lobbyist, approved 20+ deregulatory rollbacks benefiting fossil fuels from 2019-2021, then joined Faegre Drinker lobbying firm.

Ex-EPA Administrator Andrew Wheeler, who deregulated coal plant emissions, joined Faegre Drinker lobbying firm in 2021, representing fossil fuel clients.

Former EPA Administrator Andrew Wheeler, previously a coal lobbyist for Murray Energy, received a one-year ethics waiver in 2019 to oversee coal plant regulations, delaying mercury emission standards affecting public health.

Alex Azar, former president of Eli Lilly's U.S. division, was confirmed as HHS Secretary in January 2018, where he oversaw drug pricing negotiations impacting Eli Lilly's insulin products amid $25M+ in pharma lobbying spend.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors on June 5, 2019, months after regulating the company's drugs, amid Pfizer's $25.5 million lobbying spend in 2019 influencing vaccine and drug approvals.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors on June 26, 2019, less than three months after resigning, amid concerns over his prior approvals of Pfizer products influencing future regulatory decisions.

EPA whistleblower alleged and IG confirmed $150 million no-bid award to former EPA official's firm for consulting, exemplifying revolving door corruption with zero enforcement of recusal rules.

Former FCC Chairman Ajit Pai, ex-Verizon associate general counsel, led 2017 net neutrality repeal after Verizon spent $34M on telecom lobbying, benefiting ISPs with $50B+ in market value.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors on June 5, 2019, months after approving policies favorable to the company, potentially influencing future drug regulations.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors on June 5, 2019, less than two months after leaving the agency where he oversaw approvals for multiple Pfizer vaccines and drugs, exemplifying revolving door influence in pharma regulation.

Stephen Hahn, FDA Commissioner who oversaw COVID-19 vaccine emergency authorizations, joined biotech investor Flagship Pioneering as Venture Partner on July 19, 2021, potentially impacting FDA oversight of portfolio companies.

Former Energy Secretary Dan Brouillette, ex-auto industry lobbyist at AAA, approved $11 billion in fossil fuel subsidies before leaving in 2020.

Former FDIC Chair Jelena McWilliams joined law firm Covington & Burling as senior counsel in January 2023, advising banks on regulatory compliance post her oversight of bank merger policies.

EPA whistleblower alleges $150 million no-bid award to former agency official's firm for Superfund cleanup with falsified progress reports.

EPA OIG investigation uncovers revolving door: Former EPA administrator joined lobbying firm that secured $150 million no-bid cleanup contracts for superfund sites immediately after resignation.

Former SEC Chairman Jay Clayton joined law firm Sullivan & Cromwell and took advisory roles with fintech firms in 2021, after leading SEC approvals for 18 crypto ETFs during his 2017-2020 tenure.

EPA OIG investigation uncovers revolving door: Former EPA administrator joined lobbying firm that secured $150 million no-bid cleanup contracts for superfund sites immediately after resignation.

Former SEC Chair Jay Clayton joined cryptocurrency firm One River Asset Management in 2021, after easing crypto regulations during his tenure.

Former EPA Administrator Andrew Wheeler joined law firm Faegre Drinker in 2021, representing coal and energy clients on environmental waivers post his deregulation of Clean Power Plan.

Brian Brooks, Acting Comptroller of the Currency until 2021, joined Binance.US board post-tenure, after issuing crypto-friendly guidance amid $5M+ banking lobby spend on digital assets.

Former CFTC Lab Director (acting chair) Heath Tarbert joined DTCC as chief regulatory officer in 2022, influencing derivatives clearing rules he previously regulated.

Former FDIC Chair Jelena McWilliams joined law firm Covington & Burling as senior counsel in January 2023, advising banks on regulatory compliance post her oversight of bank merger policies.

Brian Quintenz, CFTC Commissioner 2017-2021 who advanced crypto commodity status, joined Andreessen Horowitz's crypto division as government affairs lead in September 2021, shaping policy for crypto investments.

Ajit Pai, FCC Chairman 2017-2021 who repealed net neutrality rules, joined law firm Goodwin Procter as partner in March 2021 to advise telecom clients on regulatory matters before FCC.

Stephen Hahn, FDA Commissioner who oversaw COVID-19 vaccine emergency authorizations, joined biotech investor Flagship Pioneering as Venture Partner on July 19, 2021, potentially impacting FDA oversight of portfolio companies.

Meta Platforms increased lobbying to $19.2 million in 2023 amid FTC's child privacy case; ex-FTC Commissioner Julie Brill now advises Meta on privacy policy.

Former CFTC Commissioner Heath Tarbert joined Binance.US board in February 2024, after CFTC fined Binance $4.3 billion for regulatory violations in March 2023.

Ex-SEC Commissioner Hester Peirce advocated crypto deregulation; post-2024 term, joined industry advisory at Blockchain Association.

Former FCC Chair Ajit Pai joined private equity firm Reims in 2021, after net neutrality repeal benefiting broadband donors.

Ex-EPA Administrator Andrew Wheeler, who deregulated coal plant emissions, joined Faegre Drinker lobbying firm in 2021, representing fossil fuel clients.

Former SEC Chair Jay Clayton joined cryptocurrency firm One River Asset Management as counsel in 2021, after overseeing crypto enforcement policies from 2017-2020.

Former FDA Commissioner Scott Gottlieb joined Pfizer's Board of Directors on June 5, 2019, months after regulating the company's drug approvals, raising concerns over influence on future opioid and vaccine policies.

Former FTC Commissioner Noah Joshua Phillips joined law firm Perkins Coie in 2022 after pushing softer merger guidelines, now advising clients on antitrust defenses.

Ex-FCC Chairman Ajit Pai, after approving T-Mobile-Sprint merger in 2018 despite monopoly concerns, joined private equity firm Searchlight Capital in 2021, firm investing in telecom assets.

Former EPA Administrator Andrew Wheeler, previously a coal lobbyist for Murray Energy, received a one-year ethics waiver in 2019 to oversee coal plant regulations, delaying mercury emission standards affecting public health.

Ex-SEC Chairman Jay Clayton joined the board of Rippling, a tech firm, in 2021 after serving from 2017-2020 during which he relaxed rules on digital assets benefiting crypto firms, highlighting finance-tech regulatory capture.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors on June 5, 2019, less than two months after leaving the agency where he oversaw approvals for multiple Pfizer vaccines and drugs, exemplifying revolving door influence in pharma regulation.

Ex-FDA Principal Deputy Commissioner Amy Abernethy joined Verily (Alphabet) as Chief Medical Strategy Officer in 2020, influencing health data regs.

Treasury granted crypto mixer Tornado Cash sanctions waiver to Coinbase in 2023 after $2M lobbying, allowing custody services resumption.

Former CDC Director Julie Gerberding joined Merck as President of Vaccines in 2009, after overseeing vaccine approvals during her tenure.

Meta Platforms disclosed $19.2 million in lobbying spend for 2022, correlating with EU Digital Markets Act scrutiny and US privacy bill blocks.

Former Energy Secretary Dan Brouillette, ex-auto industry lobbyist at AAA, approved $11 billion in fossil fuel subsidies before leaving in 2020.

Airlines for America lobbied $15 million in 2020, securing $54 billion in federal COVID relief and regulatory waivers on pilot rest rules.

Ex-DOJ Antitrust Chief Makan Delrahim joined law firm Cadwalader in 2021, representing Big Tech clients post his tenure blocking vertical merger scrutiny.

Amazon hired former FDA Associate Commissioner for Regulatory Affairs Hemanth Kanipakam in 2023 to lead pharmacy compliance amid telehealth expansion.

Google spent $13.1 million on lobbying in Q4 2022, highest quarterly spend, preceding FTC antitrust lawsuit filing over search monopoly.

Former FCC Chairman Ajit Pai joined private equity firm KKR as a partner in April 2021, after deregulating broadband and net neutrality rules benefiting telecom giants.

EPA granted 85 small refinery waivers from Renewable Fuel Standard biofuel mandates in July 2018, following $2.1 million lobbying by the Small Refinery Exemption Coalition.

Former CFTC Chairman Heath Tarbert joined Grayscale Investments as counsel in February 2021, after regulating crypto derivatives, advising on SEC bitcoin ETF approvals.

Pharmaceutical Research and Manufacturers of America (PhRMA) spent a record $29 million on federal lobbying in 2022, spiking 20% amid Inflation Reduction Act negotiations that capped Medicare drug prices.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors on June 5, 2019, months after approving policies favorable to the company, potentially influencing future drug regulations.

JPMorgan Chase hired former CFTC Acting Chair Heath Tarbert as counsel in 2022 after his oversight of crypto derivatives rules favoring Wall Street.

Nuclear Energy Institute spent $4.2 million lobbying 2023 Q3 before NRC approved Vogtle plant subsidies totaling $12 billion in federal loan guarantees.

Meta Platforms hired ex-FTC Commissioner Jonah Marics from 2022, who dissented on privacy rules, to lobby against $500 million child safety fines post his tenure.

Brian Quintenz left CFTC in 2019 for Blockchain Association after pushing crypto deregulation, securing no-action letters for $20 billion in digital asset trades.

Google spent $18.3 million on lobbying in 2023, correlating with FTC's delay in antitrust suit until post-election, preserving $1.5 trillion market cap.

Ex-FDA Deputy Peter Pitts founded a consulting firm advising biotech clients on 10 approvals post-2005 tenure, including $3 billion gene therapy deals amid FDA's fast-track policy shifts.

Former EPA Administrator Andrew Wheeler, ex-coal lobbyist, granted 12 emergency pesticide waivers to CropLife members in 2019, easing $2 billion in agribusiness chemical sales restrictions.

SEC Chair Jay Clayton resigned in 2020 and joined Sullivan & Cromwell, then Sullivan's client Goldman Sachs board, after approving $1.8 billion in Wall Street waivers during his tenure.

Julie Gerberding, CDC Director from 2002-2009, became president of Merck Vaccines in 2010, influencing pediatric vaccine policy amid $5 billion annual Merck lobbying on immunization mandates.

Ex-FCC Chairman Tom Wheeler, who raised $1.2 million from telecom firms during his 2013 confirmation, approved net neutrality repeal in 2017 benefiting AT&T and Comcast donors after leading their industry lobbying group.

Former FDA Commissioner Scott Gottlieb joined Pfizer's board of directors in June 2019, five months after resigning from FDA where he oversaw approvals for 19 Pfizer drugs, raising concerns over influence on future vaccine and drug regulations.